Christophe Georger
Evry, 91000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Dose- and genotype-dependent cardiac arrhythmia and sudden death in rats following microdystrophin gene therapy.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: March 15, 2025
Enhanced lysosomal glycogen breakdown is associated with liver tumorigenesis in glycogen storage disease type III.
Journal: JHEP reports : innovation in hepatology
Published: February 26, 2025
Synergism of dual AAV gene therapy and rapamycin rescues GSDIII phenotype in muscle and liver.
Journal: JCI insight
Published: May 26, 2023
Muscle-specific, liver-detargeted adeno-associated virus gene therapy rescues Pompe phenotype in adult and neonate Gaa-/- mice.
Journal: Journal of inherited metabolic disease
Published: December 21, 2022
Co-Administration of Simvastatin Does Not Potentiate the Benefit of Gene Therapy in the mdx Mouse Model for Duchenne Muscular Dystrophy.
Journal: International journal of molecular sciences
Published: December 08, 2021
Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy.
Journal: Nature communications
Published: August 18, 2016
Short-lived recombinant adeno-associated virus transgene expression in dystrophic muscle is associated with oxidative damage to transgene mRNA.
Journal: Molecular therapy. Methods & clinical development
Published: December 04, 2014
A phase I trial of adeno-associated virus serotype 1-γ-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2C.
Journal: Brain : a journal of neurology
Published: January 14, 2012
Identification of decorin derived peptides with a zinc dependent anti-myostatin activity.
Journal: Neuromuscular disorders : NMD
Published: January 12, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026